Horiba Jobin Yvon gained exclusive distribution rights to GenOptic’s SPRi-Lab+ detector, and the companies are comarketing the SPRi-Plex system. GE Healthcare granted Applied Biosystems and NorDiag ASA licenses to its patents for the biomagnetic isolation of nucleic acids. FujiFilm Life Sciences entered the North American market earlier this year with an agreement to market and distribute AutoGen’s QuickGene products. Biotage AB plans to enter the molecular imaging market, leveraging its solid phase extraction purification platforms and V-10 solvent evaporating system to purify SPECT/CT tracers. Exiqon A/S is distributing Luminex’s FlexmiR products for mRNA analysis, which the companies codeveloped, and instruments. Patrick G. Enright, managing director of Pequot Ventures, resigned from SEQUENOM’s Board in July. In July, Luminex named Douglas C. Bryant executive vice president and COO. Most recently, he was vice president of Abbott Vascular, Asia and Japan. In July, Lumera formed a subsidiary, Plexera Bioscience, to serve as the operations unit of its bioscience business. Board member Joseph Vallner will serve as chairman and CEO. Most recently, he was CEO of Capnia. Lumera also engaged Robert W. Baird & Co. to evaluate partnering and financing alternatives. Agilent and the National Jewish Medical and Research Center are collaborating to provide applications-focused technical training in the field of systems biology. Michael Eisenson, managing director and CEO of Charlesbank Capital Partners, resigned from Caliper Life Sciences’ Board in July. BioForce Nanosciences formed an Emerging Technologies division in July to commercialize in-house R&D. In July, Applied Biosystems announced the promotion of Mark P. Stevenson, president of the Molecular and Cell Division, to executive vice president. In addition to his current position, he assumed responsibility for the Applied Markets and Services Divisions and additional functions. The Molecular and Cell Division was divided into two divisions: MCB Systems and MCB Consumables. Tony White, chairman, president and CEO of Applera, announced in July that he expects to vacate the position of interim president of Applied Biosystems before the end of fiscal 2008.